Theradiag FIDIS Multiplexing Assays

Last updated: 18th June, 2018

The Theradiag FIDIS™ Multiplexing assays utilise Luminex® xMAP technology to simultaneously detect multiple autoantibodies in a single well. FIDIS™ assays are automated using the DSR®/Caris front-end processing systems and the Luminex 100/200 reading systems. All FIDIS™ assays have a sample protocol which allows for additional streamlining of your workflow. 

Features include:

  • Fully automated using the DSR/Caris front-end processing system 
  • Fast turnaround of results with 2x 30 minute incubations and less than 20 seconds per sample reading time using the Luminex® system
  • Control bead for sample and conjugate detection allows for confidence in results
  • MLX-Booster interpretative software
  • Bi-directional LIS interface
  • On-board Levey-Jennings QC monitoring

FIDIS™ Panels

Theradiag offer an extensive range of autoimmune panels using the FIDIS™ system to detect a wide range of autoantibodies:

  • APS Panels IgG and IgM: Cardiolipin, β2GPI and Prothrombin [Factor II].  
  • Celiac DPG IgA:  Tissue Transglutaminase (tTG) IgA, Deamidated Peptide Gliadin (DPG) IgA, Gliadin IgA
  • Celiac DPG IgG: Tissue Transglutaminase (tTG) IgG, Deamidated Peptide Gliadin (DPG) IgG, Gliadin IgG
  • dsDNA Monoplex: Human recombinant dsDNA; Standardised against the Wo 80 international standard (IU/mL)
  • Connective PROFILE Panel: 14 autoantibody specificities including UIRNP and dsDNA
  • Cyto Panel: Intrinsic Factor, Gastric Parietal Cell, Mitochondrial M2, LKM1, LC1 and Ribosomal P
  • Vasculitis Panel: MPO-ANCA, PR3-ANCA and anti-GBM
  • Thyro Panel: Thyroperoxidase (TPO) and Thyroglobulin (TG)


Find out more about FIDIS™ Multiplexing solution and IMMUNO-TROL Quality Control material

Contact Us >



Go BackGo Back